Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-08

FDA Approved: FOSAPREPITANT — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

The FDA approved a supplemental application for fosaprepitant submitted by Mylan Institutional LLC, resulting in an updated approval of the fosaprepitant produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

SUPPL AP for FOSAPREPITANT (FOSAPREPITANT)